ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 2,104 | 2,130 | 2,104 | 2,117 | +21 | +1% | 54,500 |
2021/08/18 | 2,083 | 2,110 | 2,075 | 2,096 | +24 | +1.2% | 37,200 |
2021/08/17 | 2,086 | 2,094 | 2,072 | 2,072 | -2 | -0.1% | 23,700 |
2021/08/16 | 2,080 | 2,109 | 2,074 | 2,074 | -6 | -0.3% | 59,300 |
2021/08/13 | 2,072 | 2,087 | 2,065 | 2,080 | +1 | ±0% | 36,700 |
2021/08/12 | 2,087 | 2,091 | 2,064 | 2,079 | -8 | -0.4% | 31,100 |
2021/08/11 | 2,092 | 2,093 | 2,076 | 2,087 | +20 | +1% | 22,100 |
2021/08/10 | 2,066 | 2,090 | 2,066 | 2,067 | +1 | ±0% | 43,200 |
2021/08/06 | 2,044 | 2,072 | 2,044 | 2,066 | +28 | +1.4% | 48,500 |
2021/08/05 | 2,045 | 2,066 | 2,034 | 2,038 | -14 | -0.7% | 31,300 |
2021/08/04 | 2,081 | 2,081 | 2,052 | 2,052 | -34 | -1.6% | 31,900 |
2021/08/03 | 2,122 | 2,130 | 2,081 | 2,086 | -44 | -2.1% | 33,900 |
2021/08/02 | 2,090 | 2,131 | 2,087 | 2,130 | +58 | +2.8% | 74,700 |
2021/07/30 | 2,078 | 2,089 | 2,067 | 2,072 | -17 | -0.8% | 48,900 |
2021/07/29 | 2,109 | 2,109 | 2,077 | 2,089 | -17 | -0.8% | 29,800 |
2021/07/28 | 2,108 | 2,113 | 2,096 | 2,106 | -13 | -0.6% | 26,100 |
2021/07/27 | 2,112 | 2,119 | 2,100 | 2,119 | +16 | +0.8% | 40,400 |
2021/07/26 | 2,116 | 2,116 | 2,090 | 2,103 | +8 | +0.4% | 45,500 |
2021/07/21 | 2,100 | 2,103 | 2,081 | 2,095 | +15 | +0.7% | 68,200 |
2021/07/20 | 2,063 | 2,087 | 2,059 | 2,080 | +17 | +0.8% | 47,600 |
2021/07/19 | 2,082 | 2,084 | 2,050 | 2,063 | -19 | -0.9% | 75,600 |
2021/07/16 | 2,085 | 2,100 | 2,080 | 2,082 | -7 | -0.3% | 49,900 |
2021/07/15 | 2,107 | 2,109 | 2,083 | 2,089 | -14 | -0.7% | 76,800 |
2021/07/14 | 2,098 | 2,118 | 2,095 | 2,103 | -3 | -0.1% | 92,700 |
2021/07/13 | 2,097 | 2,106 | 2,089 | 2,106 | +23 | +1.1% | 45,900 |
2021/07/12 | 2,072 | 2,100 | 2,066 | 2,083 | +31 | +1.5% | 92,100 |
2021/07/09 | 2,025 | 2,060 | 2,019 | 2,052 | +3 | +0.1% | 111,300 |
2021/07/08 | 2,036 | 2,065 | 2,036 | 2,049 | +13 | +0.6% | 85,800 |
2021/07/07 | 2,058 | 2,058 | 2,026 | 2,036 | -38 | -1.8% | 91,500 |
2021/07/06 | 2,081 | 2,083 | 2,061 | 2,074 | -7 | -0.3% | 85,500 |
2021/07/05 | 2,088 | 2,094 | 2,071 | 2,081 | -17 | -0.8% | 102,500 |
2021/07/02 | 2,104 | 2,104 | 2,090 | 2,098 | -6 | -0.3% | 105,800 |
2021/07/01 | 2,105 | 2,107 | 2,095 | 2,104 | +9 | +0.4% | 60,800 |
2021/06/30 | 2,114 | 2,115 | 2,095 | 2,095 | -13 | -0.6% | 69,800 |
2021/06/29 | 2,100 | 2,112 | 2,090 | 2,108 | -13 | -0.6% | 53,600 |
2021/06/28 | 2,115 | 2,121 | 2,099 | 2,121 | +14 | +0.7% | 62,600 |
2021/06/25 | 2,118 | 2,118 | 2,098 | 2,107 | +8 | +0.4% | 51,800 |
2021/06/24 | 2,104 | 2,113 | 2,092 | 2,099 | -5 | -0.2% | 50,100 |
2021/06/23 | 2,112 | 2,120 | 2,098 | 2,104 | -5 | -0.2% | 42,900 |
2021/06/22 | 2,068 | 2,109 | 2,062 | 2,109 | +61 | +3% | 55,100 |
2021/06/21 | 2,069 | 2,069 | 2,047 | 2,048 | -35 | -1.7% | 60,100 |
2021/06/18 | 2,102 | 2,106 | 2,083 | 2,083 | -14 | -0.7% | 94,300 |
2021/06/17 | 2,100 | 2,103 | 2,089 | 2,097 | -7 | -0.3% | 35,700 |
2021/06/16 | 2,100 | 2,106 | 2,086 | 2,104 | -2 | -0.1% | 60,300 |
2021/06/15 | 2,098 | 2,113 | 2,082 | 2,106 | +8 | +0.4% | 71,200 |
2021/06/14 | 2,119 | 2,119 | 2,094 | 2,098 | -10 | -0.5% | 52,100 |
2021/06/11 | 2,121 | 2,121 | 2,094 | 2,108 | +5 | +0.2% | 92,700 |
2021/06/10 | 2,104 | 2,110 | 2,094 | 2,103 | -12 | -0.6% | 91,500 |
2021/06/09 | 2,114 | 2,126 | 2,100 | 2,115 | +6 | +0.3% | 70,500 |
2021/06/08 | 2,096 | 2,124 | 2,095 | 2,109 | +7 | +0.3% | 87,600 |
801~
850
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム